Based on the overall results, we believe in a direct role of EZH2 in silencing of RAR beta 2, ER alpha, PGR, and RGMA genes via H3K27me3 mark in prostate cancer and therefore indicates adverse prognosis. The gene discussed is PGR; the disease is prostate carcinoma.